U of Minnesota researchers discover noninvasive diagnostic tool for brain diseasesAugust 23, 2007By recording brain cells communicating, a simple test can predict Alzheimer's, other brain diseases Researchers from the University of Minnesota Medical School and Brain Sciences Center at the Minneapolis VA Medical Center have identified a noninvasive and painless way to diagnose complex brain diseases. And it's as simple as staring at a point of light. The research offers promise for a less-stressful, painless, and objective diagnosis for brain diseases, as well as a way to measure the effectiveness of different treatments for these diseases. Using magnetoencephalography (MEG) to record tiny magnetic fields in the brain, the researchers recorded brain cells communicating with each other while research subjects stared at a point of light. After applying various mathematic algorithms, the researchers were able to classify the 142 research subjects by diagnosis. Study participants fell into one of six categories, including people with Alzheimer's disease, chronic alcoholism, schizophrenia, multiple sclerosis or Sjogren's syndrome, as well as healthy controls. The research, led by Apostolos P. Georgopoulos, M.D., Ph.D., professor of neuroscience, neurology, and psychiatry, will be published in the Aug. 27, 2007 issue of the Journal of Neural Engineering. "This elegantly simple test allows us to glimpse into the brain as it is working," Georgopoulos said. "We were able to classify, with 100 percent accuracy, the various disease groups represented in the group of research subjects." There are no good tests that measure the brain as it functions. Several tests exist to assess brain structure, but they reveal little of how the brain interacts. Currently, brain-related diseases are diagnosed with a combination of behavioral exams, psychiatric interviews, and neuropsychological testing, all which take time and can be hard on the patient, Georgopoulos said. "This discovery gives scientists and physicians another tool to assess people's disease progression," he said. "In the future it could be applied when studying the effect of new treatments or drug therapies."
All behavior and cognition in the brain involves networks of nerves continuously interacting-these interactions occur on a millisecond by millisecond basis. The MEG has 248 sensors that record the interactions in the brain on a millisecond by millisecond basis, much faster than current methods of evaluation such as the functional magnetic resonance imaging (fMRI), which takes seconds to record. The measurements they recorded represent the workings of tens of thousands of brain cells. Georgopoulos and his team were inspired to try to use the MEG as a diagnostic tool after discovering that neural interactions across human subjects were very similar. The team published on this novel way to assess the dynamic interactions of brain networks acting in synchrony in a 2006 issue of the Proceedings of the National Academy of Sciences. Now the team will continue to collect more data on the six disease groups, as well as begin to analyze research subjects with other brain diseases, including depression, post-traumatic stress disorder, autism, and Parkinson's disease, to see if the same technique can be applied. University of Minnesota | |||||||||||||||||||||
|
Related Brain Disease Current Events and Brain Disease News Articles Yale researchers unravel mystery of brain aneurysms Yale researchers have taken the first critical steps in unraveling the mysteries of brain aneurysms, the often fatal rupturing of blood vessels that afflicts 500,000 people worldwide each year and nearly killed Vice President-elect Joseph Biden two decades ago. Milestone for cannabinoid MS study The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis (MS) has been recruited to the study. New 'everyday cognition' scale tracks how older adults function in daily life As more adults age into the high-risk period for cognitive impairment, clinicians need simple and reliable methods to identify where they may have problems in everyday life that reveal underlying changes in the brain. Discovery will assist treatment and research into fatal brain disorder Research using newly developed Magnetic Resonance Imaging technology could soon allow clinicians to confirm Huntington's disease before symptoms appear in people who have the gene for the fatal brain disease. Molecular imaging sheds new light on progression of Alzheimer's disease In the past, physicians were able only to follow the progression of Alzheimer's disease (AD) through careful clinical histories, noting the often subtle changes associated with cognitive decline over a number of years. Sleeping sickness finding could lead to earlier diagnosis Sleeping sickness creates a metabolic 'fingerprint' in the blood and urine, which could enable a new test to be developed to diagnose the disease, according to new research published today in the journal Proceedings of the National Academy of Sciences. 1/3 of risk for dementia attributable to small vessel disease, autopsy study shows Alzheimer's disease may be what most people fear as they grow older, but autopsy data from a long-range study of 3,400 men and women in the Seattle region found that the brains of a third of those who had become demented before death showed evidence of small vessel damage: the type of small, cumulative injury that can come from hypertension or diabetes. New Research Shows Benefits of Ultrasound Contrast Agents Outweigh Potential Risk to Heart Patients ST. LOUIS - A Saint Louis University cardiologist called upon the U.S. Food and Drug Administration (FDA) on Monday to reconsider a strong warning it recently placed on a diagnostic tool, stating that the warning could prevent doctors from detecting life-threatening cardiac events. PET's Targeted Imaging May Lead to Earlier, More Accurate Diagnosis of Dementia and Alzheimer's Disease Researchers involved in a large, multi-institutional study using positron emission tomography (PET) imaging with the radiotracer fluorodeoxyglucose (FDG) were able to classify different types of dementia with very high rates of success, raising hopes that dementia diagnoses may one day be made at earlier stages. Surgery Improves Quality of Life for Children with Sleep Apnea, SLU Study Finds For children who suffer from obstructive sleep apnea (OSA), a tonsillectomy and adenoidectomy can provide dramatic relief and is successful in solving sleep problems for 80 to 90 percent of children, a Saint Louis University study found. More Brain Disease Current Events and Brain Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||